Clinical Trial

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer

Study acronym: WinQ
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2025 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment
Trial Details
NCT Number NCT07142096
Lead Sponsor Université Catholique de Louvain
Conditions Breast Cancer
Enrollment 20 participants
Start Date 2025-07-20
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2025-08-26